Laparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes

Diabetologia

Volumn 57, Issue 3, 2014, Pages 463-468

  Wentworth, John M ^a,b   Hensman, Tamishta ^a   Playfair, Julie ^a   Laurie, Cheryl ^a   Ritchie, Matthew E ^b,c   Brown, Wendy A ^a   Skinner, Stewart ^a   Shaw, Jonathan E ^d   O'Brien, Paul E ^a  

^a MONASH UNIVERSITY   (Australia)

^b Molecular Medicine Division   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Bariatric surgery; Diabetes prevention; Impaired fasting glucose; Obesity

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AUSTRALIA; BLOOD; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; DISEASE COURSE; FEMALE; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LAPAROSCOPY; MALE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AUSTRALIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FEMALE; GASTROPLASTY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84894515821     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3129-0     Document Type: Article

References (26)

1. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782-787
2. American Diabetes Association (2013) Standards of medical care in diabetes-2013. Diabetes Care 36(Suppl 1):S11-S66
3. Edelstein SL, Knowler WC, Bain RP et al (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701-710
4. Burke JP, Williams K, Narayan KM, Leibson C, Haffner SM, Stern MP (2003) A population perspective on diabetes prevention: whom should we target for preventing weight gain? Diabetes Care 26:1999-2004
5. Ramachandran A, Snehalatha C, Mary S et al (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289-297
6. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393-403
7. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
8. Li G, Zhang P, Wang J et al (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371(9626):1783-1789
9. Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077
10. DeFronzo RA, Tripathy D, Schwenke DC et al (2011) Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med 364:1104-1115
11. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27:155-161
12. Garvey WT, Ryan DH, Look M et al (2012) Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 95:297-308
13. O'Brien P, McDonald L, Anderson M, Brennan L, Brown WA (2013) Long term outcomes after bariatric surgery: fifteen year follow up after gastric banding and a systematic review of the literature. Ann Surg 257:87-94
14. Dixon JB, O'Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc 299:316-323
15. Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366(17):1577-1585
16. Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567-1576
17. Carlsson LM, Peltonen M, Ahlin S et al (2012) Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 367(8):695-704
18. Magliano DJ, Barr EL, Zimmet PZ et al (2008) Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 31(2):267-272
19. American Diabetes Association (2010) Standards of medical care in diabetes - 2010. Diabetes Care 33(Suppl 1):S11-S61
20. Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829-834
21. Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. J Am Med Assoc 308:2489-2496
22. Colditz GA, Willett WC, Stampfer MJ et al (1990) Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132:501-513
23. Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790-797
24. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17(9):961-969
25. Cobourn C, Mumford D, Chapman MA, Wells L (2010) Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg 20:415-422
26. Longitudinal Assessment of Bariatric Surgery C, Flum DR, Belle SH et al (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445-454